About
Small Molecules for Oncology
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
1,196
By Phase
PHASE1: 3PHASE2: 1PHASE1/PHASE2: 2
By Status
RECRUITING: 3ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07029399Lead Sponsor
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
PHASE1Recruiting
205 participants
Started: Mar 25, 2025 · Completed: Dec 31, 2027
NCT06586957Lead Sponsor
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
PHASE1Recruiting
150 participants
Started: Sep 19, 2024 · Completed: May 31, 2029
NCT06264921Lead Sponsor
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
PHASE1Terminated
23 participants
Started: Feb 23, 2024 · Completed: Apr 16, 2025
NCT05935748Lead Sponsor
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
PHASE2Active, not recruiting
172 participants
Started: Jul 28, 2023 · Completed: Jun 30, 2026
NCT05119335Lead Sponsor
A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
128 participants
Started: Oct 26, 2021 · Completed: Sep 30, 2026
Funding History (1)
D
Jun 7, 2021
Locations (1)
Headquarters
Wilmington, DE, United States
Map
Loading map...